Psychiatry and Mental Health Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
National University of Distance Education (UNED), Madrid, Spain.
BMC Psychiatry. 2019 Jul 29;19(1):233. doi: 10.1186/s12888-019-2206-4.
People who suffer a first episode of psychosis experience higher levels of distress and suffering. Early intervention programs combine pharmacological and psychosocial strategies that include different components, such as cognitive-behavioural therapy, psychosocial interventions, medication adherence, family psychoeducation, counselling, etc. Among the complementary approaches, mindfulness-based interventions help participants to cultivate a radical acceptance of their psychotic experiences within a person-centered framework. They show promising results for people with longer duration of psychosis, but there is still no evidence for people who have recently experienced their first episode of psychosis.
The present parallel-group, single-blind (evaluator), randomised (1:1 ratio), controlled (versus active comparator), superiority, clinical trial will compare the effectiveness of SocialMIND on social functioning as measured by the Personal and Social Performance (PSP) scale. The active comparator will be a psychoeducational multicomponent intervention (PMI) that incorporates elements of early intervention programs that are effective for people who have suffered a first episode of psychosis. Both SocialMIND and PMI encompass eight weekly sessions, four bi-weekly sessions, and five monthly sessions. Changes in primary and secondary outcomes will be measured after weekly (8th week), bi-weekly (16th week) and monthly sessions (56th week), and 3 months after completing the intervention (68th week). Secondary outcomes include symptoms of psychosis, anxiety and depression, as well as indicators of general functioning. Tertiary outcomes are measures of social cognition, neurocognition, mindfulness, and indicators of inflammation and oxidative stress. A final sample of 80 participants is proposed to detect clinically significant differences in social functioning.
This is the first mindfulness-based social cognition training for people with psychosis. SocialMIND aims to generate changes in the real-life functioning of people who have experienced a first episode of psychosis, and to be at least as effective as a psychoeducational multicomponent program. Adherence to the interventions is a common problem among young people with psychosis, so several difficulties are anticipated, and some methodological issues are discussed.
The trial was registered in ClinicalTrials.gov in October 2018 (NCT03309475).
首次出现精神病症状的人会经历更高水平的痛苦和苦难。早期干预计划结合了药物和心理社会策略,其中包括认知行为疗法、心理社会干预、药物依从性、家庭心理教育、咨询等不同的组成部分。在补充方法中,基于正念的干预有助于参与者在以人为中心的框架内对他们的精神病体验进行彻底接受。它们为精神病持续时间较长的人带来了有希望的结果,但对于最近经历首次精神病发作的人仍没有证据。
本项平行组、单盲(评估者)、随机(1:1 比例)、对照(与活性对照物相比)、优效性、临床试验将比较 SocialMIND 对个人和社会表现(PSP)量表衡量的社会功能的有效性。活性对照物将是一种心理教育多成分干预(PMI),它包含对首次精神病发作的人有效的早期干预计划的元素。SocialMIND 和 PMI 都包含八周的每周一次课程、四周两次的课程和五个每月的课程。主要和次要结果的变化将在每周(第 8 周)、两周一次(第 16 周)和每月(第 56 周)以及干预结束后 3 个月(第 68 周)进行测量。次要结果包括精神病症状、焦虑和抑郁,以及一般功能的指标。三级结果是社会认知、神经认知、正念以及炎症和氧化应激的指标的测量。建议纳入 80 名参与者的最终样本,以检测首次精神病发作患者社会功能的临床显著差异。
这是针对精神病患者的第一个基于正念的社会认知训练。SocialMIND 的目的是改变首次精神病发作患者的现实生活功能,并且至少与心理教育多成分计划一样有效。年轻人患有精神病时,坚持干预措施是一个常见的问题,因此预计会遇到一些困难,并讨论了一些方法学问题。
该试验于 2018 年 10 月在 ClinicalTrials.gov 注册(NCT03309475)。